Home / 2018

2018

Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl

The alpha-2 adrenergic receptor antagonist, yohimbine, can facilitate fear extinction in animals and humans. One potential mechanism is increased noradrenergic activity and associated arousal in the presence of conditioned stimuli. Accordingly, yohimbine might augment prolonged exposure (PE) therapy for posttraumatic stress disorder (PTSD), where heightened exposure-oriented arousal is a theorized …

Read More »

Meta-analysis of the effects of cognitive-behavioral therapy on the core eating disorder maintaining mechanisms: Implications for mechanisms of therapeutic change

Cognitive-behavioural therapy (CBT) is the most effective psychological treatment for a variety of eating disorder presentations in adults. However, little is known about how, why, or through what mechanisms, CBT achieves its effects. The cognitive theory that underpins cognitive-behavioural treatment proposes that CBT “works” through modifying dietary restraint and dysfunctional …

Read More »

Linguistic Analysis of Patients with Mood and Anxiety Disorders During Cognitive Behavioral Therapy

Patients’ words reflect their depression and anxiety We express ourselves in words, intentionally as well as unintentionally, and verbal behavior is influenced by emotional, cognitive and personality factors. Furthermore, words are the essential medium of psychotherapy. Up till now, language has mainly been investigated qualitatively, however, progress in the field …

Read More »